icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Successful Retreatment of HCV Genotype-1 Infected Patients Who Failed Prior Therapy with Peg-interferon + Ribavirin Plus 1 or 2 Other Direct-Acting Antiviral Agents with Sofosbuvir
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Stanislas Pol1, Mark Sulkowski2, Tarek Hassanein3, Ed Gane4, Liyun Ni5, Hongmei Mo5, Bittoo Kanwar5, Diana Brainard5, GM Subramanian5, William T. Symonds5, John G. McHutchison5, Michael Bennett6, Ira M. Jacobson7
1Universite Paris Decartes, Hopital Cochin, Paris, France; 2John Hopkins University, Baltimore, MD, USA; 3Southern California Liver Center, Coronado, CA, USA; 4Aukland City Hospital, Auckland, NZ; 5Gilead Sciences, Inc., Foster City, CA, USA; 6Medical Associates Research Group, San Diego, CA, USA; 7Weill Cornell Medical College, New York, NY, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif